Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism.
溶血磷脂酰乙醇胺 18:1 通过稳定 SIRT6 来重编程脂质代谢,从而驱动透明细胞肾细胞癌的发生。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02496-1
Yue Nanxi, Zhao Hongye, Zhang Yong, Gu Junfei, Qi Jinchun, Wen Jinkun, Wang Wei, Lv Mingming, Sun Hao, Chen Jinsuo, Yang Chenxiao, Qu Changbao, Chen Xiaonan, Yang Zhan